SPOTLIGHT: Pfizer to turn Esperion back to Newton

Pfizer snapped up Esperion Therapeutics four years ago, hip to its cholesterol candidates, but shut it down last year. Now, Esperion will relaunch as a private company with its previous leader, Roger Newton, at the helm. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.